Paroxysmal Nocturnal Hemoglobinuria Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ACH-4471
1.2.3 ALN-CC5
1.2.4 ALXN-1210
1.2.5 AMY-101
1.2.6 APL-2
1.2.7 Others
1.3 Market by Application
1.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Perspective (2017-2028)
2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Growth Trends by Region
2.2.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Historic Market Size by Region (2017-2022)
2.2.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Region (2023-2028)
2.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Dynamics
2.3.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Industry Trends
2.3.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Drivers
2.3.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Challenges
2.3.4 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Revenue
3.1.1 Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Revenue (2017-2022)
3.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
3.4 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Concentration Ratio
3.4.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in 2021
3.5 Paroxysmal Nocturnal Hemoglobinuria Treatment Key Players Head office and Area Served
3.6 Key Players Paroxysmal Nocturnal Hemoglobinuria Treatment Product Solution and Service
3.7 Date of Enter into Paroxysmal Nocturnal Hemoglobinuria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paroxysmal Nocturnal Hemoglobinuria Treatment Breakdown Data by Type
4.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Historic Market Size by Type (2017-2022)
4.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Type (2023-2028)
5 Paroxysmal Nocturnal Hemoglobinuria Treatment Breakdown Data by Application
5.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Historic Market Size by Application (2017-2022)
5.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2017-2028)
6.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
6.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
6.2.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028)
6.2.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
6.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
6.3.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
6.3.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028)
6.3.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
6.4 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
6.4.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022)
6.4.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2017-2028)
7.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
7.2.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
7.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028)
7.2.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
7.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
7.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
7.3.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028)
7.3.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
7.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
7.4.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022)
7.4.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2017-2028)
8.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
8.2.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
8.3.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region
8.4.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2017-2028)
9.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
9.2.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
9.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
9.3.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
9.4 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
9.4.1 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (2017-2028)
10.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
10.2.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
10.3.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country
10.4.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Achillion Pharmaceuticals Inc
11.1.1 Achillion Pharmaceuticals Inc Company Details
11.1.2 Achillion Pharmaceuticals Inc Business Overview
11.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.1.4 Achillion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.1.5 Achillion Pharmaceuticals Inc Recent Developments
11.2 Akari Therapeutics Plc
11.2.1 Akari Therapeutics Plc Company Details
11.2.2 Akari Therapeutics Plc Business Overview
11.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.2.4 Akari Therapeutics Plc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.2.5 Akari Therapeutics Plc Recent Developments
11.3 Alexion Pharmaceuticals Inc
11.3.1 Alexion Pharmaceuticals Inc Company Details
11.3.2 Alexion Pharmaceuticals Inc Business Overview
11.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.3.4 Alexion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.3.5 Alexion Pharmaceuticals Inc Recent Developments
11.4 Alnylam Pharmaceuticals Inc
11.4.1 Alnylam Pharmaceuticals Inc Company Details
11.4.2 Alnylam Pharmaceuticals Inc Business Overview
11.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.4.4 Alnylam Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.4.5 Alnylam Pharmaceuticals Inc Recent Developments
11.5 Amgen Inc
11.5.1 Amgen Inc Company Details
11.5.2 Amgen Inc Business Overview
11.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.5.4 Amgen Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.5.5 Amgen Inc Recent Developments
11.6 Apellis Pharmaceuticals Inc
11.6.1 Apellis Pharmaceuticals Inc Company Details
11.6.2 Apellis Pharmaceuticals Inc Business Overview
11.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.6.4 Apellis Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.6.5 Apellis Pharmaceuticals Inc Recent Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Details
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.7.5 F. Hoffmann-La Roche Ltd Recent Developments
11.8 ISU ABXIS Co Ltd
11.8.1 ISU ABXIS Co Ltd Company Details
11.8.2 ISU ABXIS Co Ltd Business Overview
11.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.8.4 ISU ABXIS Co Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.8.5 ISU ABXIS Co Ltd Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.9.4 Novartis AG Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.9.5 Novartis AG Recent Developments
11.10 NovelMed Therapeutics Inc
11.10.1 NovelMed Therapeutics Inc Company Details
11.10.2 NovelMed Therapeutics Inc Business Overview
11.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.10.4 NovelMed Therapeutics Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.10.5 NovelMed Therapeutics Inc Recent Developments
11.11 Omeros Corp
11.11.1 Omeros Corp Company Details
11.11.2 Omeros Corp Business Overview
11.11.3 Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.11.4 Omeros Corp Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.11.5 Omeros Corp Recent Developments
11.12 Ra Pharmaceuticals Inc
11.12.1 Ra Pharmaceuticals Inc Company Details
11.12.2 Ra Pharmaceuticals Inc Business Overview
11.12.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.12.4 Ra Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.12.5 Ra Pharmaceuticals Inc Recent Developments
11.13 Regeneron Pharmaceuticals Inc
11.13.1 Regeneron Pharmaceuticals Inc Company Details
11.13.2 Regeneron Pharmaceuticals Inc Business Overview
11.13.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.13.4 Regeneron Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.13.5 Regeneron Pharmaceuticals Inc Recent Developments
11.14 Regenesance BV
11.14.1 Regenesance BV Company Details
11.14.2 Regenesance BV Business Overview
11.14.3 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Introduction
11.14.4 Regenesance BV Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
11.14.5 Regenesance BV Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of ACH-4471
Table 3. Key Players of ALN-CC5
Table 4. Key Players of ALXN-1210
Table 5. Key Players of AMY-101
Table 6. Key Players of APL-2
Table 7. Key Players of Others
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Region (2017-2022)
Table 12. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Region (2023-2028)
Table 14. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trends
Table 15. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Drivers
Table 16. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Challenges
Table 17. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Restraints
Table 18. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players (2017-2022)
Table 20. Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment as of 2021)
Table 21. Ranking of Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Paroxysmal Nocturnal Hemoglobinuria Treatment Product Solution and Service
Table 25. Date of Enter into Paroxysmal Nocturnal Hemoglobinuria Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Type (2017-2022)
Table 29. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Type (2023-2028)
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Application (2017-2022)
Table 33. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Application (2023-2028)
Table 35. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 65. Achillion Pharmaceuticals Inc Company Details
Table 66. Achillion Pharmaceuticals Inc Business Overview
Table 67. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 68. Achillion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 69. Achillion Pharmaceuticals Inc Recent Developments
Table 70. Akari Therapeutics Plc Company Details
Table 71. Akari Therapeutics Plc Business Overview
Table 72. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 73. Akari Therapeutics Plc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 74. Akari Therapeutics Plc Recent Developments
Table 75. Alexion Pharmaceuticals Inc Company Details
Table 76. Alexion Pharmaceuticals Inc Business Overview
Table 77. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 78. Alexion Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 79. Alexion Pharmaceuticals Inc Recent Developments
Table 80. Alnylam Pharmaceuticals Inc Company Details
Table 81. Alnylam Pharmaceuticals Inc Business Overview
Table 82. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 83. Alnylam Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 84. Alnylam Pharmaceuticals Inc Recent Developments
Table 85. Amgen Inc Company Details
Table 86. Amgen Inc Business Overview
Table 87. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 88. Amgen Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 89. Amgen Inc Recent Developments
Table 90. Apellis Pharmaceuticals Inc Company Details
Table 91. Apellis Pharmaceuticals Inc Business Overview
Table 92. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 93. Apellis Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 94. Apellis Pharmaceuticals Inc Recent Developments
Table 95. F. Hoffmann-La Roche Ltd Company Details
Table 96. F. Hoffmann-La Roche Ltd Business Overview
Table 97. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 98. F. Hoffmann-La Roche Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 99. F. Hoffmann-La Roche Ltd Recent Developments
Table 100. ISU ABXIS Co Ltd Company Details
Table 101. ISU ABXIS Co Ltd Business Overview
Table 102. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 103. ISU ABXIS Co Ltd Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 104. ISU ABXIS Co Ltd Recent Developments
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 108. Novartis AG Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 109. Novartis AG Recent Developments
Table 110. NovelMed Therapeutics Inc Company Details
Table 111. NovelMed Therapeutics Inc Business Overview
Table 112. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 113. NovelMed Therapeutics Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 114. NovelMed Therapeutics Inc Recent Developments
Table 115. Omeros Corp Company Details
Table 116. Omeros Corp Business Overview
Table 117. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 118. Omeros Corp Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 119. Omeros Corp Recent Developments
Table 120. Ra Pharmaceuticals Inc Company Details
Table 121. Ra Pharmaceuticals Inc Business Overview
Table 122. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 123. Ra Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 124. Ra Pharmaceuticals Inc Recent Developments
Table 125. Regeneron Pharmaceuticals Inc Company Details
Table 126. Regeneron Pharmaceuticals Inc Business Overview
Table 127. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 128. Regeneron Pharmaceuticals Inc Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 129. Regeneron Pharmaceuticals Inc Recent Developments
Table 130. Regenesance BV Company Details
Table 131. Regenesance BV Business Overview
Table 132. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Product
Table 133. Regenesance BV Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022) & (US$ Million)
Table 134. Regenesance BV Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type: 2021 VS 2028
Figure 2. ACH-4471 Features
Figure 3. ALN-CC5 Features
Figure 4. ALXN-1210 Features
Figure 5. AMY-101 Features
Figure 6. APL-2 Features
Figure 7. Others Features
Figure 8. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application: 2021 VS 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Paroxysmal Nocturnal Hemoglobinuria Treatment Report Years Considered
Figure 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Region: 2021 VS 2028
Figure 16. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Players in 2021
Figure 17. Global Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Treatment as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in 2021
Figure 19. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2028)
Figure 21. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2028)
Figure 22. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Share by Country (2017-2028)
Figure 23. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2028)
Figure 27. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2028)
Figure 28. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Share by Country (2017-2028)
Figure 29. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Share by Region (2017-2028)
Figure 39. China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Share by Country (2017-2028)
Figure 49. Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Share by Country (2017-2028)
Figure 55. Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Achillion Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 59. Akari Therapeutics Plc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 60. Alexion Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 61. Alnylam Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 62. Amgen Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 63. Apellis Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 64. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 65. ISU ABXIS Co Ltd Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 66. Novartis AG Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 67. NovelMed Therapeutics Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 68. Omeros Corp Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 69. Ra Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 70. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 71. Regenesance BV Revenue Growth Rate in Paroxysmal Nocturnal Hemoglobinuria Treatment Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Industry Market Size
